Cancer claims nearly 10 million lives annually, making it one of the leading causes of death globally. Yet, advanced treatment often remains financially and logistically out of reach for many.
The introduction of Multiple Cancer Early Detection (MCED) screenings and wellness check-ups marks a significant step forward in cancer prevention. These diagnostic tools are able to identify multiple types of cancer, including detection of anomalies and possible breast, lung, colorectal, pancreatic, prostate, stomach, esophageal, liver, and uterine cancers at the earliest stages—even before symptoms arise.
By detecting cancers as early as stage 0, MCED screening empowers individuals to take proactive steps with the assistance of medical professionals, significantly reducing treatment costs and improving the eventual survival rates, even detecting the possibilities of cancers two-to-five years in advance.
“It cannot be emphasised any clearer that early detection is the key to saving lives,” said COO of Stemcell First Group Allen Law. “MCED screening service ensures that patients have the chance to address cancer risks earlier before they become life-threatening and provide the
applicable solution to mitigate the risk.”
The early detection is coupled with an advanced cell and gene therapy centre offering innovative treatment, including CAR-T cell therapy, targeting specifically a variety of cancers such as leukaemia, lymphoma, myeloma, pancreatic cancer, ovarian cancer, colorectal cancer, melanoma, sarcoma, bladder cancer, peritoneal and pleural cancers, nasopharyngeal cancer (NPC), EGFR lung cancer, and cervical cancer.
According to Stemcell First, the regenerative therapy centre locally highlights the pressing need to bridge the healthcare gaps in Malaysia and the region. This is because, for many, access to advanced treatments has often required travelling abroad at great financial and emotional cost to an already distressed or fatigued patient who is trying their best to be psychologically resilient.
